Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denufosol (INS37217) Phase 1b/2a in CF
NCT00034515Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Jun 2001
- Primary completion
- Aug 2002
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of denufosol tetrasodium in cystic fibrosis (CF), sponsored by Merck & Co.. Started Jun 2001; status: completed.
02
Drugs
denufosol tetrasodium
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT00034515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00034515.